User profiles for A. Sharabi

Andrew Sharabi

UCSD
Verified email at ucsd.edu
Cited by 5855

Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy

AB Sharabi, M Lim, TL DeWeese, CG Drake - The lancet oncology, 2015 - thelancet.com
Checkpoint blockade immunotherapy has received mainstream attention as a result of striking
and durable clinical responses in some patients with metastatic disease and a reasonable …

Regulatory T cells in the treatment of disease

A Sharabi, MG Tsokos, Y Ding, TR Malek… - Nature reviews Drug …, 2018 - nature.com
Regulatory T (T reg ) cells suppress inflammation and regulate immune system activity. In
patients with systemic or organ-specific autoimmune diseases or those receiving transplanted …

[HTML][HTML] Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer

RR Raval, AB Sharabi, AJ Walker, CG Drake… - … for immunotherapy of …, 2014 - Springer
Abstract Knowledge of the basic mechanisms of the immune system as it relates to cancer
has been increasing rapidly. These developments have accelerated the translation of these …

Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts

…, S Molzer, C Zoratti, R Malli, A Sharabi… - Journal of cell …, 2004 - journals.biologists.com
Trophoblast invasion of the uterine extracellular matrix, a critical process of human implantation
and essential for fetal development, is a striking example of controlled invasiveness. To …

Hyperprogressors after immunotherapy: analysis of genomic alterations associated with accelerated growth rate

…, V Walavalkar, DA Barkauskas, A Sharabi… - Clinical Cancer …, 2017 - AACR
Purpose: Checkpoint inhibitors demonstrate salutary anticancer effects, including long-term
remissions. PD-L1 expression/amplification, high mutational burden, and mismatch repair …

Stereotactic radiation therapy augments antigen-specific PD-1–mediated antitumor immune responses via cross-presentation of tumor antigen

AB Sharabi, CJ Nirschl, CM Kochel, TR Nirschl… - Cancer immunology …, 2015 - AACR
The immune-modulating effects of radiotherapy (XRT) have gained considerable interest
recently, and there have been multiple reports of synergy between XRT and immunotherapy. …

Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy

…, Y Muroyama, RA Anders, AB Sharabi… - Clinical Cancer …, 2018 - AACR
Purpose: In the proper context, radiotherapy can promote antitumor immunity. It is unknown
if elective nodal irradiation (ENI), a strategy that irradiates tumor-associated draining lymph …

B cells improve overall survival in HPV-associated squamous cell carcinomas and are activated by radiation and PD-1 blockade

…, JS Gutkind, EEW Cohen, JA Califano, AB Sharabi - Clinical Cancer …, 2020 - AACR
Purpose: To characterize the role of B cells on human papilloma virus (HPV)-associated
cancer patient outcomes and determine the effects of radiation and PD-1 blockade on B-cell …

T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy

A Sharabi, GC Tsokos - Nature Reviews Rheumatology, 2020 - nature.com
T cell subsets are critically involved in the development of systemic autoimmunity and organ
inflammation in systemic lupus erythematosus (SLE). Each T cell subset function (such as …

[HTML][HTML] Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC

…, AB Simon, BA Fox, JD Bui, A Sharabi… - Nature …, 2022 - nature.com
Despite the promise of immune checkpoint inhibition (ICI), therapeutic responses remain
limited. This raises the possibility that standard of care treatments delivered in concert may …